A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the safety and tolerability of escalating doses of
the MM-121 plus cetuximab and the MM-121 plus cetuximab plus irinotecan combination.